E-LIB Suche - Ergebnisse für: Tahiri, Andliena

1

The NEOLETRIB trial: neoadjuvant treatment with Letrozole a..:

Fjermeros, Kamilla ; Ghannoum, Salim ; Geisler, Stephanie B....
Future Oncology. , 2024

Link: https://doi.org/10.1080/..

2

Benign breast tumors may arise on different immunological b..:

Torland, Lilly Anne ; Lai, Xiaoran ; Kumar, Surendra...
Molecular Oncology. , 2024

Link: https://doi.org/10.1002/..

3

The breast cancer coagulome in the tumor microenvironment a..:

Tinholt, Mari ; Tekpli, Xavier ; Torland, Lilly Anne...
Journal of Thrombosis and Haemostasis. 22 (2024) 5 - p. 1319-1335 , 2024

Link: https://doi.org/10.1016/..

4

High-throughput screen in vitro identifies dasatinib as a c..:

Normann, Lisa Svartdal ; Haugen, Mads Haugland ; Hongisto, Vesa...
PLOS ONE. 18 (2023) 1 - p. e0280507 , 2023

Link: https://doi.org/10.1371/..

5

Kinase activity profiling in renal cell carcinoma, benign r..:

Tahiri, Andliena ; Puco, Katarina ; Naji, Faris...
Oncotarget. 13 (2022) 1 - p. 970-981 , 2022

Link: https://doi.org/10.18632..

6

Lack of cross-resistance between non-steroidal and steroida..:

Bahrami, Nazli ; Jabeen, Shakila ; Tahiri, Andliena...
Breast Cancer Research and Treatment. 190 (2021) 3 - p. 435-449 , 2021

Link: https://doi.org/10.1007/..

7

Loss of progesterone receptor is associated with distinct t..:

Tahiri, Andliena ; Tekpli, Xavier ; Satheesh, Somisetty V....
Breast Cancer Research and Treatment. 183 (2020) 3 - p. 585-598 , 2020

Link: https://doi.org/10.1007/..

8

miRNA551b-3p Activates an Oncostatin Signaling Module for t..:

Parashar, Deepak ; Geethadevi, Anjali ; Aure, Miriam Ragle...
Cell Reports. 29 (2019) 13 - p. 4389-4406.e10 , 2019

Link: https://doi.org/10.1016/..

9

Age, estrogen, and immune response in breast adenocarcinoma..:

Quigley, David A. ; Tahiri, Andliena ; Lüders, Torben...
OncoImmunology. 6 (2017) 11 - p. e1356142 , 2017

Link: https://doi.org/10.1080/..

10

Data-driven analysis of immune infiltrate in a large cohort..:

Dannenfelser, Ruth ; Nome, Marianne ; Tahiri, Andliena...
Oncotarget. 8 (2017) 34 - p. 57121-57133 , 2017

Link: https://doi.org/10.18632..

11

Differential Inhibition of Ex-Vivo Tumor Kinase Activity by..:

Tahiri, Andliena ; Røe, Kathrine ; Ree, Anne H....
PLoS ONE. 8 (2013) 8 - p. e72692 , 2013

Link: https://doi.org/10.1371/..

12

Deregulation of cancer-related miRNAs is a common event in ..:

Tahiri, Andliena ; Leivonen, Suvi-Katri ; Lüders, Torben...
Carcinogenesis. 35 (2013) 1 - p. 76-85 , 2013

Link: https://doi.org/10.1093/..

13

High-throughput screen in vitro identifies dasatinib as a c..:

Normann, Lisa Svartdal ; Haugen, Mads ; Hongisto, Vesa...
Normann, Lisa Svartdal Haugen, Mads Hongisto, Vesa Aure, Miriam Ragle Leivonen, Suvi-Katri Kristensen, Vessela N. Tahiri, Andliena Engebråten, Olav Sahlberg, Guro Kristine Kleivi Mælandsmo, Gunhild Mari . High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer. PLOS ONE. 2023, 18(1). , 2023

Link: http://hdl.handle.net/10..

14

High-throughput screen in vitro identifies dasatinib as a c..:

Normann, Lisa Svartdal ; Haugen, Mads ; Hongisto, Vesa...
PLOS ONE. , 2023

Link: https://hdl.handle.net/1..

15

High-throughput screen in vitro identifies dasatinib as a c..:

Normann, Lisa Svartdal ; Haugen, Mads Haugland ; Hongisto, Vesa...
10.1371/journal.pone.0280507. , 2023

Link: http://hdl.handle.net/10..